Cargando…

Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers

Cystic fibrosis is the most common and best known genetic disease involving a defect in transepithelial Cl- transport by mutations in the CF gene on chromosome 7, which codes for the cystic fibrosis transmembrane conductance regulator protein (CFTR). The most serious symptoms are observed in the lun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coutinho, Henrique Douglas M, Falcão-Silva, Vivyanne S, Gonçalves, Gregório Fernandes
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586015/ https://www.ncbi.nlm.nih.gov/pubmed/18992146 http://dx.doi.org/10.1186/1755-7682-1-24

Ejemplares similares

Molecular ageing in progeroid syndromes: Hutchinson-Gilford progeria syndrome as a model
por: Coutinho, Henrique Douglas M, et al.
Publicado: (2009)

Herbal therapy associated with antibiotic therapy: potentiation of the antibiotic activity against methicillin – resistant Staphylococcus aureus by Turnera ulmifolia L
por: Coutinho, Henrique DM, et al.
Publicado: (2009)

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
por: Vandeplassche, Eva, et al.
Publicado: (2019)

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis
por: Kadeřábková, Nikol, et al.
Publicado: (2023)

Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis
por: Psoter, Kevin J., et al.
Publicado: (2017)

Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages
por: Shrestha, Chandra L., et al.
Publicado: (2017)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Bicarbonate Inhibits Bacterial Growth and Biofilm Formation of Prevalent Cystic Fibrosis Pathogens
por: Dobay, Orsolya, et al.
Publicado: (2018)

Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis
por: Gavillet, Helen, et al.
Publicado: (2022)

Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis()
por: Hoppe, Jordana E., et al.
Publicado: (2018)

Bacterial Subversion of Autophagy in Cystic Fibrosis
por: Flores-Vega, Verónica Roxana, et al.
Publicado: (2021)

Saliva as a potential tool for cystic fibrosis diagnosis
por: Gonçalves, Aline Cristina, et al.
Publicado: (2013)

The Contribution of Membrane Vesicles to Bacterial Pathogenicity in Cystic Fibrosis Infections and Healthcare Associated Pneumonia
por: Vitse, Jolien, et al.
Publicado: (2020)

Pulmonary Bacterial Communities in Surgically Resected Noncystic Fibrosis Bronchiectasis Lungs Are Similar to Those in Cystic Fibrosis
por: Maughan, Heather, et al.
Publicado: (2012)

Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis — Is it good for the patient?
por: Sequeiros, Iara Maria, et al.
Publicado: (2009)

Effect of N-Acetylcysteine in Combination with Antibiotics on the Biofilms of Three Cystic Fibrosis Pathogens of Emerging Importance
por: Aiyer, Aditi, et al.
Publicado: (2021)

Synergistic Antimicrobial Effects of Ibuprofen Combined with Standard-of-Care Antibiotics against Cystic Fibrosis Pathogens
por: Chen, Qingquan, et al.
Publicado: (2023)

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
por: Roehmel, Jobst, et al.
Publicado: (2014)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

1151. Candida Colonization Alters Pathogenic Pulmonary Infection in Pediatric Patients with Cystic Fibrosis
por: Parsons, Emily, et al.
Publicado: (2020)

The Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic Fibrosis
por: Depluverez, Sofie, et al.
Publicado: (2016)

The Microbiome in Cystic Fibrosis Pulmonary Disease
por: Françoise, Alice, et al.
Publicado: (2020)

Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung
por: Planet, Paul J
Publicado: (2022)

Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis
por: Nunvar, Jaroslav, et al.
Publicado: (2016)

Bacterial activity in cystic fibrosis lung infections
por: Rogers, Geraint B, et al.
Publicado: (2005)

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
por: VanDevanter, Donald R, et al.
Publicado: (2010)

Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis
por: Kennedy, Charles, et al.
Publicado: (2022)

Antibiotic Therapy for Pulmonary Exacerbations in Cystic Fibrosis—A Single-Centre Prospective Observational Study
por: Schwarz, Carsten, et al.
Publicado: (2023)

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
por: Fraser-Pitt, Douglas, et al.
Publicado: (2016)

Modulation of the norfloxacin resistance in Staphylococcus aureus by Cordia verbenaceae DC
por: Matias, Edinardo F.F., et al.
Publicado: (2013)

Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis
por: Coutinho, Cyntia Arivabeni de Araújo Correia, et al.
Publicado: (2013)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
por: Li, Danni, et al.
Publicado: (2023)

Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy
por: Müller, Ulrike, et al.
Publicado: (2015)

2578. Trends in Pathogens and Antibiotic Treatment in Children with Cystic Fibrosis in 2018 and 2022: A Retrospective Multicenter Study
por: Stout, Dayna, et al.
Publicado: (2023)

Body Composition and Pulmonary Function in Cystic Fibrosis
por: Sheikh, Saba, et al.
Publicado: (2014)

Pulmonary Nocardiosis in an Immunocompetent Patient with Cystic Fibrosis
por: Schoen, Lucy, et al.
Publicado: (2015)

Pulmonary Tuberculosis in a Patient with Cystic Fibrosis
por: Patil, Naveen, et al.
Publicado: (2015)

Pulmonary aspiration in preschool children with cystic fibrosis
por: Clarke, D., et al.
Publicado: (2018)

Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
por: Velino, Cecilia, et al.
Publicado: (2019)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c59n9igih0l0b58eio5lkl5a51